Loading organizations...
Loading organizations...
Next-generation immuno-corrective therapy for autoimmune patients.
Autoimmunity BioSolutions has raised $2.0M across 1 funding round.
Autoimmunity BioSolutions has raised $2.0M in total across 1 funding round.
Autoimmunity BioSolutions has raised $2.0M in total across 1 funding round.
Autoimmunity BioSolutions's investors include Eos Bioinnovation.
Autoimmunity BioSolutions has raised $2.0M across 1 funding round. Most recently, it raised $2.0M Seed in November 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 28, 2024 | $2.0M Seed | Eos Bioinnovation |